The effectiveness removes the last barrier for noteholders to sell shares into the market. Given the company's weak fundamentals (net loss, going-concern) and high volatility, monitor for any Form 4 filings indicating insider selling or a drop in share price as overhang materializes.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $7.85entry
- T+1 · 4d ago −7.90%α −7.53% · $7.23
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Picard Medical's S-3 shelf registration (File No. 333-299579) became effective on November 10, 2026, enabling the resale of up to 500,000 shares issuable upon conversion of $1.0M in convertible notes and exercise of pre-funded warrants. The company receives no proceeds, but the effectiveness adds potential near-term overhang of ~20% dilution relative to 2.46M shares outstanding.
Key Facts
- S-3 shelf registration (333-299579) declared effective on November 10, 2026
- Registers up to 500,000 shares for resale by selling stockholders
- Shares issuable upon conversion of $1.0M convertible notes (issued Sep 30, 2026) and exercise of pre-funded warrants
- Company receives no proceeds from the resale
- Potential dilution of ~20.3% relative to 2,458,574 shares outstanding
- Market cap is $20M; stock has high volatility (11.8% normal daily move)
- Company reported 2025 revenue of $4.94M but net loss of $27M with going-concern qualification
Financial Impact
Up to 500,000 shares (20.3% of outstanding) can be sold by noteholders; no new capital raised
Risk Factors
- Potential near-term selling by noteholders could pressure the stock price
- Company has going-concern qualification and NYSE non-compliance notice
- High volatility (11.8% normal daily move) amplifies price impact of any selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003504 |
| Document: 9999999995-26-003504-index.html | 9999999995-26-003504 |
| Document: 9999999995-26-003504.txt | 9999999995-26-003504 |
Track record
27 reports on PMI
5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +138.72% at T+60 after the Jul 27, 2026 report. 11 of 13 went positive at some point.
Filters
- Nov 16, 2026today Press Release Bearish 6/10 Entry $7.24 Now $7.24 +0.00% settles Feb 16
- Nov 12, 20265d ago EFFECT Bearish 5/10 Viewing Entry $7.85 Now $7.24 +7.77% settles Feb 10
- Nov 5, 202611d ago S-3/A Bearish 5/10 Entry $9.00 Now $7.24 +19.56% settles Feb 4
- Nov 3, 202613d ago 8-K Bearish 5/10 Entry $7.19 Now $7.24 −0.70% settles Feb 2
- Oct 23, 202624d ago 8-K Mixed 5/10 Entry $6.43 Now $7.24 +12.60% settles Jan 22
- Oct 22, 202625d ago S-3 Bearish 6/10 Entry $7.37 Now $7.24 +1.76% settles Jan 20
- Oct 6, 20265w ago 8-K Bearish 6/10 Entry $8.74 Now $7.24 +17.16% settles Dec 31
- Jul 27, 202616w ago 8-K Bullish 6/10 Entry $0.0878 to $0.2096 Now $7.24 +8146.01% ▲ +138.72% +134.67% vs SPY
- Jul 15, 202617w ago DEFA14A Neutral 2/10 Entry $0.1600 to $0.1896 Now $7.24 +4425.00% ▲ +18.50% +14.79% vs SPY
- Jul 8, 202618w ago DEFA14A Neutral 2/10 Entry $0.1500 to $0.0864 Now $7.24 +4726.67% ▼ −42.40% −44.89% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers